Santalum album mouthwash - Santalis

Drug Profile

Santalum album mouthwash - Santalis

Alternative Names: Albuterpenoid - Santalis; East Indian Sandalwood Oil (EISO) mouth rinse - Santalis; SAN-005

Latest Information Update: 28 Jun 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Santalis Pharmaceuticals
  • Class Anti-infectives; Phytotherapies; Skin disorder therapies
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Stomatitis

Most Recent Events

  • 20 May 2017 Santalis Pharmaceuticals completes a phase II trial for Stomatitis in USA (NCT02399228)
  • 09 Sep 2016 Santalis Pharmaceuticals has patent protection for santalum album mouthwash in Japan
  • 17 Mar 2015 Clinical trials in Stomatitis in USA (Buccal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top